Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of August 2026, with the report dated August 11, 2026. The filing primarily addresses a change in the composition of the Company's Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
- Board Resignation: Mr. Vincent Chun Hung Chan resigned as a member of the Board of Directors, effective August 14, 2026. The resignation was not related to any disagreement with the Company regarding operations, policies, or practices.
- Board Appointment: The Board appointed Mr. David Salton as an independent director and a Class II director until the 2027 annual general meeting.
- Committee Assignments: Mr. Salton will serve on the Compensation Committee, Audit Committee, and Financial Statement Examination Committee.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of operational risks. It notes that the Company expects to enter into a standard indemnification and exemption agreement with Mr. Salton. There are no related party transactions involving Mr. Salton required to be disclosed under Item 7.B of Form 20-F.
Key Facts for Investor Verification
- Confirm the effective date of Mr. Chan's resignation (August 14, 2026) and the immediate appointment of Mr. Salton.
- Verify Mr. Salton's extensive background in medical device startups and his prior directorships at SHL Telemedicine, ARAN Research & Development, and InterCure Inc.
- Note that this filing is incorporated by reference into the Company's active Registration Statements on Form F-3 and Form S-8.